• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学处理增强了抗肌萎缩蛋白基因突变外显子的跳跃。

Chemical treatment enhances skipping of a mutated exon in the dystrophin gene.

机构信息

Department of Pediatrics, Kobe University Graduate School of Medicine, Chuo, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan.

出版信息

Nat Commun. 2011;2:308. doi: 10.1038/ncomms1306.

DOI:10.1038/ncomms1306
PMID:21556062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3113229/
Abstract

Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disease caused by a loss of the dystrophin protein. Control of dystrophin mRNA splicing to convert severe DMD to a milder phenotype is attracting much attention. Here we report a dystrophinopathy patient who has a point mutation in exon 31 of the dystrophin gene. Although the mutation generates a stop codon, a small amount of internally deleted, but functional, dystrophin protein is produced in the patient cells. An analysis of the mRNA reveals that the mutation promotes exon skipping and restores the open reading frame of dystrophin. Presumably, the mutation disrupts an exonic splicing enhancer and creates an exonic splicing silencer. Therefore, we searched for small chemicals that enhance exon skipping, and found that TG003 promotes the skipping of exon 31 in the endogenous dystrophin gene in a dose-dependent manner and increases the production of the dystrophin protein in the patient's cells.

摘要

杜氏肌营养不良症(DMD)是一种致命的肌肉萎缩疾病,由肌营养不良蛋白的缺失引起。控制肌营养不良蛋白 mRNA 的剪接,将严重的 DMD 转化为更温和的表型,这引起了广泛关注。本文报道了一名肌营养不良症患者,其肌营养不良蛋白基因第 31 外显子发生点突变。尽管该突变产生了一个终止密码子,但在患者细胞中仍会产生少量内部缺失但具有功能的肌营养不良蛋白。对 mRNA 的分析表明,该突变促进了外显子跳跃,并恢复了肌营养不良蛋白的开放阅读框。推测该突变破坏了外显子剪接增强子并创建了外显子剪接沉默子。因此,我们寻找了能促进外显子跳跃的小分子化合物,发现 TG003 能以剂量依赖的方式促进内源性肌营养不良蛋白基因第 31 外显子的跳跃,并增加患者细胞中肌营养不良蛋白的产生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/d528f6ea148d/ncomms1306-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/5debca3a9325/ncomms1306-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/9254f9174467/ncomms1306-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/301b411bfbf9/ncomms1306-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/d528f6ea148d/ncomms1306-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/5debca3a9325/ncomms1306-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/9254f9174467/ncomms1306-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/301b411bfbf9/ncomms1306-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c45a/3113229/d528f6ea148d/ncomms1306-f4.jpg

相似文献

1
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene.化学处理增强了抗肌萎缩蛋白基因突变外显子的跳跃。
Nat Commun. 2011;2:308. doi: 10.1038/ncomms1306.
2
A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy.由DMD基因第45外显子缺失连接产生的一种新型剪接沉默子可以解释修饰肌营养不良症的上游第44外显子跳跃现象。
J Hum Genet. 2014 Aug;59(8):423-9. doi: 10.1038/jhg.2014.36. Epub 2014 May 29.
3
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.将人类杜氏肌营养不良症(DMD)成纤维细胞直接重编程为肌管,用于体外评估反义介导的外显子跳跃以及外显子45 - 55跳跃并伴有肌营养不良蛋白表达恢复的情况。
Methods Mol Biol. 2018;1828:141-150. doi: 10.1007/978-1-4939-8651-4_8.
4
An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.肌营养不良蛋白基因中一个与外显子跳跃相关的无义突变揭示了多个拮抗剪接元件之间的复杂相互作用。
Hum Mol Genet. 2006 Mar 15;15(6):999-1013. doi: 10.1093/hmg/ddl015. Epub 2006 Feb 6.
5
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.反义诱导的外显子跳跃可恢复杜氏肌营养不良症(DMD)患者来源的肌肉细胞中的抗肌萎缩蛋白表达。
Hum Mol Genet. 2001 Jul 15;10(15):1547-54. doi: 10.1093/hmg/10.15.1547.
6
A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.肌营养不良蛋白缺乏型小型骑士查理王小猎犬存在杜兴氏肌营养不良症基因热点突变,可采用外显子 51 跳跃法进行治疗。
PLoS One. 2010 Jan 13;5(1):e8647. doi: 10.1371/journal.pone.0008647.
7
Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.缺失肌营养不良蛋白框内第5外显子导致严重表型:外显子跳跃策略指南。
PLoS One. 2016 Jan 8;11(1):e0145620. doi: 10.1371/journal.pone.0145620. eCollection 2016.
8
Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.多外显子跳跃导致产生一种缺失外显子45至55氨基酸的人工杜兴肌营养不良蛋白,这可以挽救高达63%的杜兴肌营养不良患者。
Hum Mutat. 2007 Feb;28(2):196-202. doi: 10.1002/humu.20428.
9
Exon skipping therapy for Duchenne muscular dystrophy.外显子跳跃疗法治疗杜氏肌营养不良症。
Adv Drug Deliv Rev. 2015 Jun 29;87:104-7. doi: 10.1016/j.addr.2015.05.008. Epub 2015 May 14.
10
Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene.无义突变相关的贝克型肌营养不良症:DMD 基因中外显子定义和剪接调控元件之间的相互作用。
Hum Mutat. 2011 Mar;32(3):299-308. doi: 10.1002/humu.21426.

引用本文的文献

1
Invention of an oral medication for cardiac Fabry disease caused by RNA mis-splicing.针对由RNA错配剪接引起的心脏法布里病的口服药物发明。
Sci Adv. 2025 Apr 11;11(15):eadt9695. doi: 10.1126/sciadv.adt9695. Epub 2025 Apr 9.
2
Mesoscale proximity labeling to study macro changes to chromatin occupancy.用于研究染色质占据宏观变化的中尺度邻近标记法。
bioRxiv. 2025 Mar 15:2025.03.13.643041. doi: 10.1101/2025.03.13.643041.
3
Clinical Characteristics of Patients With Becker Muscular Dystrophy Having Pathogenic Microvariants or Duplications.

本文引用的文献

1
RNA-targeted splice-correction therapy for neuromuscular disease.针对神经肌肉疾病的 RNA 靶向剪接校正治疗。
Brain. 2010 Apr;133(Pt 4):957-72. doi: 10.1093/brain/awq002. Epub 2010 Feb 11.
2
Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.全基因组 RNAi 筛选鉴定出流感病毒复制所必需的人类宿主因子。
Nature. 2010 Feb 11;463(7282):818-22. doi: 10.1038/nature08760. Epub 2010 Jan 17.
3
Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
患有致病性微变异或重复的贝克型肌营养不良患者的临床特征
Neurol Genet. 2024 Dec 17;11(1):e200215. doi: 10.1212/NXG.0000000000200215. eCollection 2025 Feb.
4
Small molecules modulating RNA splicing: a review of targets and future perspectives.调节RNA剪接的小分子:靶点及未来展望综述
RSC Med Chem. 2024 Jan 11;15(4):1109-1126. doi: 10.1039/d3md00685a. eCollection 2024 Apr 24.
5
Branchpoints as potential targets of exon-skipping therapies for genetic disorders.分支点作为遗传性疾病外显子跳跃疗法的潜在靶点。
Mol Ther Nucleic Acids. 2023 Jul 17;33:404-412. doi: 10.1016/j.omtn.2023.07.011. eCollection 2023 Sep 12.
6
Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases.Cdc2 样激酶:结构、生物学功能及疾病治疗靶点。
Signal Transduct Target Ther. 2023 Apr 7;8(1):148. doi: 10.1038/s41392-023-01409-4.
7
Targeting splicing factors for cancer therapy.针对剪接因子的癌症治疗。
RNA. 2023 Apr;29(4):506-515. doi: 10.1261/rna.079585.123. Epub 2023 Jan 25.
8
The nexus between RNA-binding proteins and their effectors.RNA 结合蛋白与其效应物之间的联系。
Nat Rev Genet. 2023 May;24(5):276-294. doi: 10.1038/s41576-022-00550-0. Epub 2022 Nov 23.
9
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia.剪接体:慢性髓性白血病的新治疗靶点
Cancers (Basel). 2022 Sep 27;14(19):4695. doi: 10.3390/cancers14194695.
10
Inhibition of NR5A1 Phosphorylation Alleviates a Transcriptional Suppression Defect Caused by a Novel Mutation.抑制NR5A1磷酸化可减轻由新型突变引起的转录抑制缺陷。
J Endocr Soc. 2022 Apr 22;6(6):bvac068. doi: 10.1210/jendso/bvac068. eCollection 2022 Jun 1.
血管内皮生长因子(VEGF)剪接从促血管生成到抗血管生成异构体的调节:一种新的血管生成治疗策略。
J Biol Chem. 2010 Feb 19;285(8):5532-40. doi: 10.1074/jbc.M109.074930. Epub 2009 Nov 11.
4
RNA-targeting approaches for neuromuscular diseases.针对神经肌肉疾病的 RNA 靶向治疗方法。
Trends Mol Med. 2009 Dec;15(12):580-91. doi: 10.1016/j.molmed.2009.10.005. Epub 2009 Nov 10.
5
The SR protein family.SR 蛋白家族。
Genome Biol. 2009;10(10):242. doi: 10.1186/gb-2009-10-10-242. Epub 2009 Oct 27.
6
Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing.疱疹病毒蛋白ICP27通过改变mRNA剪接来转换PML异构体。
Nucleic Acids Res. 2009 Oct;37(19):6515-27. doi: 10.1093/nar/gkp633. Epub 2009 Sep 3.
7
Less is more: therapeutic exon skipping for Duchenne muscular dystrophy.少即是多:杜氏肌营养不良症的治疗性外显子跳跃
Lancet Neurol. 2009 Oct;8(10):873-5. doi: 10.1016/S1474-4422(09)70229-7. Epub 2009 Aug 25.
8
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.在杜兴氏肌营养不良症中使用吗啉代寡聚物AVI-4658进行肌营养不良蛋白表达的局部恢复:一项单盲、安慰剂对照、剂量递增的概念验证研究。
Lancet Neurol. 2009 Oct;8(10):918-28. doi: 10.1016/S1474-4422(09)70211-X. Epub 2009 Aug 25.
9
Cooperative-binding and splicing-repressive properties of hnRNP A1.异质性核糖核蛋白A1的协同结合与剪接抑制特性
Mol Cell Biol. 2009 Oct;29(20):5620-31. doi: 10.1128/MCB.01678-08. Epub 2009 Aug 10.
10
Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.拮抗型SR蛋白在PI3激酶和Wnt信号通路下游调节肿瘤相关Rac1b的可变剪接。
Hum Mol Genet. 2009 Oct 1;18(19):3696-707. doi: 10.1093/hmg/ddp317. Epub 2009 Jul 13.